Marijuana, Joint, Bud, Pot, Nug

$50 Million Gets You Seattle’s Top Marijuana Retail Stores

The top two retail marijuana chains in Seattle have joined forces and put their six retail outlets on the market for $50 million. Depending on whether you see marijuana legalization flourishing ...
Read Full Story »
Jon's friends

Wednesday’s Top Biopharma Winners

The third week of the New Year is halfway over, and a few biopharma companies made massive runs on the day. The health care sector was in trouble over the ...
Read Full Story »
bigger fish

What Eli Lilly Gets With CoLucid Acquisition

Eli Lilly and Co. (NYSE: LLY) has announced it has reached an agreement to acquire CoLucid Pharmaceuticals Inc. (NASDAQ: CLCD) in an all-cash transaction for $46.50 per share, or about ...
Read Full Story »
Female patient on gurney

Tuesday’s Top Biopharma Movers

Some biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off. ...
Read Full Story »
medical cannabis

Marijuana News Roundup: The Rewards and Risks of Cannabis Use

The National Academies of Sciences, Engineering, and Medicine last Thursday released a 400-page review of more than 10,000 research abstracts published since 1999 on the health impacts of cannabis and ...
Read Full Story »
cannabis plants

Marijuana Price Rises 2% to $1,568 a Pound

For the week ended Friday, January 13, 2017, the spot price index for a pound of cannabis increased by 2.3% from $1,532 in the prior week to $1,568. According to ...
Read Full Story »
Concept photograph of cannabis leaf made of US dollar bills

Which Privately Held Firms Have a Bright Outlook for 2017?

By now the 2017 outlook for all sorts of asset classes has been sliced and diced by legions of commenters. There have even been a number of prognostications related to ...
Read Full Story »

Can NFL Help National Painkiller Epidemic?

The National Football League (NFL) is inarguably the top sports league in the United States. Television networks pay billions of dollars annually for the right to show NFL games, and to ...
Read Full Story »
Good heart health

Thursday’s Biggest Biopharma Winners

The health care sector was in trouble over the past year, coming under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »

Biotech Short Sellers Run for Cover

The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
100 dollar bills

Wednesday’s Top Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive ...
Read Full Story »
Valeant Pharmaceuticals

Why Valeant Is Making a Run

Valeant Pharmaceuticals International Inc. (NYSE: VRX) made waves early on Tuesday after the company offered a plethora of announcements. First the company gave an update on its late-stage psoriasis trial. ...
Read Full Story »

Monday’s Merger That No One Saw Coming

Mergers and acquisitions are a way for companies to come together and complement each other’s business models. Most M&A makes sense. Whether companies need to consolidate within an industry or ...
Read Full Story »
Doctor, Health (pulse) copy

Monday’s 4 Biggest Biopharma Movers

The second week of the New Year is now underway, and a few biotech companies made sizable runs to kick off the week. The health care sector was in trouble ...
Read Full Story »